Tue, January 23, 2018
Mon, January 22, 2018
Fri, January 19, 2018
Thu, January 18, 2018
Wed, January 17, 2018
Tue, January 16, 2018
Fri, January 12, 2018
Thu, January 11, 2018
Wed, January 10, 2018
Tue, January 9, 2018
Mon, January 8, 2018
Fri, January 5, 2018
Thu, January 4, 2018
Wed, January 3, 2018
Tue, January 2, 2018
Tue, December 26, 2017
Fri, December 22, 2017
Thu, December 21, 2017
Wed, December 20, 2017
Tue, December 19, 2017
Mon, December 18, 2017
Fri, December 15, 2017
Thu, December 14, 2017
Wed, December 13, 2017

Madhu Kumar Initiated (ABUS) at Strong Buy and Held Target at $10 on, Jan 5th, 2018


//stocks-investing.news-articles.net/content/201 .. g-buy-and-held-target-at-10-on-jan-5th-2018.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Madhu Kumar of B. Riley Securities, Initiated "Arbutus Biopharma Corporation" (ABUS) at Strong Buy and Held Target at $10 on, Jan 5th, 2018.

Madhu has made no other calls on ABUS in the last 4 months.



There is 1 other peer that has a rating on ABUS. Out of the 1 peers that are also analyzing ABUS, all agrees with Madhu's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Michael Schmidt of "Leerink Swann" Maintained at Hold with Increased Target to $5.5 on, Tuesday, November 7th, 2017

Publication Contributing Sources